SANIYA
AGGARWAL
Temple University School of Pharmacy
|
| Faculty
Sponsor: |
Scott M. Rawls, Ph.D. |
| Faculty
Sponsor Title: |
Assistant Professor, Pharmacology |
| Major: |
Pharm.D. |
| GPA: |
3.86/4.00 |
| Expected
Graduation: |
May 2010 |
|
Focus
of Research:
|
To determine
if agmatine enhances the analgesic effect of cannabinoid administration
and if it also eliminates addictive qualities and withdrawal effects
of cannabinoid. The most clinically relevant focus of this research
project is to determine if agmatine prevents the development of tolerance
to the analgesic effects of repeated annabinoid administration. If
is determined that agmatine administration alters the pharmacologic
effects of marijuana and cannabinoid agonists, then the endogenous
agmatine system will be identified as a key drug target for treating
tolerance and addiction. |
| Title
of Research: |
“Agmatine
Regulation of Cannabinoid Analgesia.” |
| Degrees
Received: |
Pre-Pharmacy, Temple University,
May 2006 |
| Honors
Received: |
2006-2004,
Dean’s List; 2006, Honors Completion Award; 2004, Edward Seidel
Math Award, Bordentown Regional Teacher Assistant Award, Deborah Heart
& Lung Healthcare Scholarship |
| AFPE
Award: |
American
Association of Pharmaceutical Scientists - AFPE Gateway To Research
Scholarship |
|
DIANA
X. CAO
University of Southern California School of Pharmacy
|
| Faculty
Sponsor: |
Wei-Chiang Shen, Ph.D. |
| Faculty
Sponsor Title: |
Professor, Pharmaceutical
Sciences |
| Major: |
Pharm.D. |
| GPA: |
4.0/4.0 |
| Expected
Graduation: |
May 2009 |
| Focus
of Research: |
To elucidate
the signal transduction pathway that eventually leads to the transcription
of pro-apoptotic factors. Insight into this pathway may contribute
to the development of novel therapeutic approaches to improve the
outcome of cancer therapy. |
| Title
of Research: |
“A
Novel Pro-Apoptotic Pathway Modulated by ATM and SUMOylation.” |
| Degrees
Received: |
B.S., Biochemistry and
Molecular & Cellular Biology, University of California at Davis,
December 2005 |
| Honors
Received: |
2007, Rho Chi
Book Award; 2006, Alvah Hall Endowment Scholarship, Paul Davis Endowed
Scholarship, Graduation with Departmental Citation; 2003, James and
Leta Fulmor Scholarship, M.L. Bailey Memorial Scholarship |
| AFPE
Award: |
AstraZeneca
Pharmaceuticals - AFPE Gateway To Research Scholarship |
|
JUSTIN
M. JULIUS
Duquesne University Mylan School of Pharmacy
|
| Faculty
Sponsor: |
Paula A. Witt-Enderby,
Ph.D. |
| Faculty
Sponsor Title: |
Associate Professor, Pharmacology/Toxicology |
| Major: |
Pharm.D. |
| GPA: |
3.85/4.00 |
| Expected
Graduation: |
May 2009 |
| Focus
of Research: |
To further define
the binding pockets of the human MT1 and MT2 melatonin receptors using
novel melatonin receptor ligands to develop novel and subtype-selective
ligands to further define the role of melatonin within the body, beyond
current understanding of its use as a sleep aid. |
| Title
of Research: |
“Pharmacological
Evaluation of 13a, 14 dihydro-6H-pyrazino (1,2-a;4,5-a) diindole Analogs
as Melatonin Receptor Ligands Using Competition Binding Analysis and
Recombinant Cell Lines Expressing the Human MT1 and MT2 Melatonin
Receptors.” |
| Degrees
Received: |
N/A |
| Honors
Received: |
2007-2003,
Dean’s List |
| AFPE
Award: |
American
Association of Colleges of Pharmacy - AFPE Gateway to Research Scholarship |
|
BRYAN
R. KUDLAWIEC
Duquesne University Mylan School of Pharmacy
|
| Faculty
Sponsor: |
Aleem Gangjee, Ph.D. |
| Faculty
Sponsor Title: |
Professor, Medicinal Chemistry |
| Major: |
Pharm.D. |
| GPA: |
3.98/4.00 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To develop and
research compounds possessing anti-tumor activity that target many
sites of cancer cells and produce cancer cell death. One goal is to
research compounds that possess multiple binding sites to induce cell
death through many cyto-toxic mechanisms. Another goal is to research
compounds that create cell death specific to only cancer cells while
harming very little normal cells in the human body. |
| Title
of Research: |
“Synthesis
of Tyrosine Kinase Inhibitors as Anti-Tumor Agents.” |
| Degrees
Received: |
N/A |
| Honors
Received: |
2007-05, Dean’s
List; 2005, Directors Circle, Phi Eta Sigma - Freshmen Honor Society;
2004, Duquesne Merit Scholarship |
| AFPE
Award: |
Johnson
& Johnson Pharmaceutical R&D - AFPE Gateway To Research Scholarship |
|
PHUONG
L. H. NGUYEN
Southern Illinois University at Edwardsville School of Pharmacy
|
| Faculty
Sponsor: |
Guim Kwon, Ph.D. |
| Faculty
Sponsor Title: |
Assistant Professor, Pharmaceutical
Sciences |
| Major: |
Pharm.D. |
| GPA: |
3.82/.4.00 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To elucidate
molecular mechanisms involved in the reduction of pancreatic beta-cell
mass associated with obesity-mediated Type 2 diabetes and to test
the hypothesis that elevated glucose concentrations cause MTOR-mediated
hyperplasia that leads to beta-cell death due to the cell cycle or
mitochondrial defect. The goal is to contribute to the development
of anti-diabetic agents that prevent the onset of Type 2 diabetes
by preserving pancreatic beta-cell mass. |
| Title
of Research: |
“Mechanisms
Involved in Glucotoxicity-Mediated Beta-Cell Failure During the Pathogenesis
of Obesity-Mediated Type 2 Diabetes.” |
| Degrees
Received: |
B.A., Chemistry, Saint
Louis University |
| Honors
Received: |
2007, 2004-03,
Dean’s List; 2002, Phi Theta Kappa |
| AFPE
Award: |
Pfizer
Inc. - AFPE Gateway To Research Scholarship |
|
NEENA
S. PHADKE
Purdue University School of Pharmacy and Pharmaceutical Sciences
|
| Faculty
Sponsor: |
James E. Tisdale, Pharm.D. |
| Faculty
Sponsor Title: |
Professor, Pharmacy Practice |
| Major: |
Pharm.D. |
| GPA: |
3.95/4.00 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To determine
the efficacy and safety of amiodarone for prevention of atrial fibrillation
(AF) after noncardiac thoracic surgery (NCTS), to determine the influence
of atrial fibrillation prevention on duration of hospital stay, and
to determine predictors and mechanisms of post-NCTS atrial fibrillation.
This clinical study is enrolling 240 patients undergoing NCTS. |
| Title
of Research: |
“Prevention
and Mechanisms of Atrial Fibrillation Following Noncardiac Thoracic
Surgery.” |
| Degrees
Received: |
N/A |
| Honors
Received: |
2007-04, Dean’s
List; 2007, Mortar Board Senior Honor Society, Order of Omega Greek
Leadership Honor Society; 2006, Rho Chi Honor Certificate; 2004, National
Merit Scholar |
| AFPE
Award: |
Pfizer
Inc. - AFPE Gateway To Research Scholarship |
|
CONNIE
M. REMSBERG
Washington State University College of Pharmacy
|
| Faculty
Sponsor: |
Neal M. Davies, Ph.D. |
| Faculty
Sponsor Title: |
Associate Professor, Medicinal/Pharmaceutical
Chemistry |
| Major: |
Pharm.D. |
| GPA: |
4.0/4.0 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To focus on several
hydrophobic xenobiotics: paclitaxel, pterostilbene, and phloretin.
The in vitro efficacy of pterostilbene and phloretin will be examined
in combination with paclitaxel in a spectrum of breast cancers. The
pharmacokinetics, tissue distribution, and tolerable dose of polymeric
micelle formulations of paclitaxel, pterostilbene, and phloretin will
also be determined. Finally, pterostilbene and phloretin will be examined
in combination with paclitaxel and alone in mouse xenografts. This
research reflects the increased emphasis on research of xenobiotics
found in natural products as they may provide antioxidant, anti-cancer,
anti-inflammatory, and other health benefits. |
| Title
of Research: |
“Pharmaceutical
Engineering of Nanocarriers for Delivery of Hydrophobic Xenobiotics.” |
| Degrees
Received: |
B.S., Biology, University
of Idaho, May 2006 |
| Honors
Received: |
2006, Sigma
Xi Undergraduate Scholar Award; 2006-05, Undergraduate Student Poster
Presentation Winner; 2005, Dr. Paul Ellis Memorial Scholarship; 2005,03,
Charlie Langer and Ella Boyle Stanley Scholarship |
| AFPE
Award: |
Ortho-McNeil
Janssen Scientific Affairs - AFPE Gateway To Research Scholarship |
|
JESSE
R. RICKELMAN
University of Illinois at Chicago College of Pharmacy
|
| Faculty
Sponsor: |
Richard A. Gemeinhart,
Ph.D. |
| Faculty
Sponsor Title: |
Assistant Professor, Biopharmaceutical
Sciences |
| Major: |
Pharm.D. |
| GPA: |
3.72/4.00 |
| Expected
Graduation: |
May 2008 |
| Focus
of Research: |
To determine
optimal characteristics of hydrogels as effective drug delivery devices
with limited side effects by focusing on the release of chemotherapeutic
drugs from a polymeric device. The activation of the chemotherapeutic
drugs will be mediated by matrix metalloproteases that are released
from tumors. The specific goal of the research is to optimize the
matrix metalloprotease sensitivity of the hydrogel therapeutics and
to optimize the hydrogel parameters within the hydrogel therapeutics.
The utilization of hyrogels as drug delivery devices may be a significant
innovation in providing localized drug therapy. |
| Title
of Research: |
“Drug
Activation from Hydrogel Therapeutics.” |
| Degrees
Received: |
N/A |
| Honors
Received: |
N/A |
| AFPE
Award: |
Frederick
W. Telling Endowed - AFPE Gateway To Research Scholarship |
|
NICOLE
SALATA
University of Illinois at Chicago College of Pharmacy
|
| Faculty
Sponsor: |
Hayat Onyuksel, Ph.D. |
| Faculty
Sponsor Title: |
Professor, Pharmaceutics
and Bioengineering |
| Major: |
Pharm.D. |
| GPA: |
3.38/4.00 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To further investigate
a previously developed nanomedicine for Alzheimer’s Disease
in three ways by first, determining if intranasal delivery is feasible
in transgenic mice; second, by determining the appropriate in vivo
therapeutic dose in transgenic mice using intranasal delivery; and
third, by determining the in vivo safety and efficacy of the nanomedicine
in transgenic mice specific to Alzheimer’s Disease, using intranasal
delivery. |
| Title
of Research: |
“In
Vivo Efficacy of Novel Bifunctional Nanomedicine for Alzheimer’s
Disease in Transgenic Mice Model.” |
| Degrees
Received: |
B.A., Spanish, University
of Illinois at Urbana-Champaign, May 2005 |
| Honors
Received: |
2004-03,
Dean’s List; 2003,01, General Assembly Scholarship; 2001, Illinois
State Scholar |
| AFPE
Award: |
sanofi-aventis
- AFPE Gateway To Research Scholarship |
|
THOMAS
SHUM
Purdue University School of Pharmacy and Pharmaceutical Sciences
|
| Faculty
Sponsor: |
Arun K. Ghosh, Ph.D. |
| Faculty
Sponsor Title: |
Professor, Medicinal Chemistry |
| Major: |
B.S., Pharmaceutical Sciences |
| GPA: |
3.83/4.00 |
| Expected
Graduation: |
May 2009 |
| Focus
of Research: |
To create an
inhibitor for the neuraminidase enzyme in the HPAI A(HN51) influenza
virus using a structure-based organic synthesis. The research will
involve collaborating with other researchers to obtain protein crystal
structure analysis of the binding affinity between synthesized molecules
and the target enzyme. |
| Title
of Research: |
“Design
and Synthesis of Neuraminidase Inhibitors Targeting the H5N1 Avian
Influenza Strain.” |
| Degrees
Received: |
N/A |
| Honors
Received: |
2007, Eli Lilly Merit
Scholarship; 2006-05, Dean’s List |
| AFPE
Award: |
American
Association of Pharmaceutical Scientists - AFPE Gateway To Research
Scholarship |
|
CHARLES
S. VENUTO
State University of New York at Buffalo School of Pharmacy and Pharmaceutical
Sciences
|
| Faculty
Sponsor: |
Gene D. Morse, Pharm.D. |
| Faculty
Sponsor Title: |
Professor; Chair, Associate
Dean, Clinical Education and Research |
| Major: |
Pharm.D. |
| GPA: |
3.6/4.0 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
Genetic variations
of the MDR1 gene encoding for the membrane efflux pump, P-glycoprotein,
and the genes encoding CYP3A4, provide pharmacokinetic consequences
when optimizing drug regimens. This variation is further implicated
in HIV-infected individuals taking antiretroviral therapy such as
protease inhibitors. By associating the genetic polymorphisms with
the expression of P-glycoprotein and CYP3A4, this research will seek
to obtain a more specific and accurate metabolism profile, allowing
therapeutic adjustments and optimal therapy to proceed in HIV-infected
patients. |
| Title
of Research: |
“Pharmacogenomics
of Protease Inhibitors in Patients with HIV infection.” |
| Degrees
Received: |
B.S., Molecular and Microbiology,
University of Central Florida, May 2006 |
| Honors
Received: |
2006, School
of Pharmacy Dean’s List; 2006-02, Bright Futures Scholarship |
| AFPE
Award: |
Pfizer
Inc. - AFPE Gateway To Research Scholarship |
|
TYLER
R. WHISMAN
University of Kentucky College of Pharmacy
|
| Faculty
Sponsor: |
Wendell S. Akers, Pharm.D. |
| Faculty
Sponsor Title: |
Associate Professor, Pharmacy
Practice and Science |
| Major: |
Pharm.D. |
| GPA: |
3.91/4.00 |
| Expected
Graduation: |
May 2008 |
| Focus
of Research: |
To evaluate the
concentration-dependent effects of RB006 and RB007 on platelet function
in human blood samples. A secondary objective of this study is to
compare the effects of anticoagulating blood samples with sodium citrate,
PPACK or RB006 on resting and agonist-induced platelet activation.
An aptamer (RB006) and complementary antidote (RB007) that inhibits
Factor Xia has been recently developed to test in humans. The purpose
of this research is to evaluate their ex vivo effect on platelet function
and modify the responsiveness to antiplatelet agents. |
| Title
of Research: |
“The
Effect of RB006 and RB007 on In Vitro Platelet Activation in Human
Blood.” |
| Degrees
Received: |
B.A., Biology, Thomas
More College, May 2004 |
| Honors
Received: |
2007, Dean Earl P. Slone
Award, Albert Turk Award; 2006, Runner-up NCPA Pruitte-Schutte Business
Plan Competition, ASHP National Student Leadership Award; 2005, Kappa
Psi Upsilon -Pledge of the Year |
| AFPE
Award: |
Procter
& Gamble - AFPE Gateway To Research Fellowship |
|
LING
XU
University of Minnesota Twin Cities College of Pharmacy
|
| Faculty
Sponsor: |
James C. Cloyd, Pharm.D. |
| Faculty
Sponsor Title: |
Professor, Experimental
and Clinical Pharmacology |
| Major: |
Pharm.D. |
| GPA: |
3.95/4.00 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To demonstrate,
in controlled clinical trials, the neuroprotective and antiseizure
effects of topiramate in neonates with congenital heart disease undergoing
heart surgery. Given that the number of newborns undergoing corrective
heart surgery is 5-15,000 per year, intravenous topiramate is being
developed as an orphan drug. The aim of the research is to determine
the pharmacokinetics, pharmacodynamics, and safety of topiramate given
intravenously to newborn rats and piglets. The project aims to develop
an existing drug into an injectable formulation to treat hypoxic brain
injury and seizures in newborns undergoing surgery. |
| Title
of Research: |
“Use
of Intraveneous Topiramate for Neuroprotection in Newborns Undergoing
Heart Surgery.” |
| Degrees
Received: |
B.S., Biochemistry, University
of Minnesota, Twin Cities, May 2006 |
| Honors
Received: |
2007, 2nd
Place, CLARION Case Competition, Semi-finalist,OTC Case Competition;
2006, Peters Academic Scholarship, Dean’s List |
| AFPE
Award: |
American
Association of Pharmaceutical Scientists - AFPE Gateway To Research
Scholarship |
|
SHANNON
L. ZANDY
University of Florida College of Pharmacy
|
| Faculty
Sponsor: |
Joanna Peris, Ph.D. |
| Faculty
Sponsor Title: |
Associate Professor, Pharmacodynamics |
| Major: |
Pharm.D. |
| GPA: |
3.41/4.00 |
| Expected
Graduation: |
May 2010 |
| Focus
of Research: |
To determine
how intermittent high dose ethanol exposure affects ethanol responding
in selfadministering rats and the neurochemical changes associated
with that responding. The use of on-line capillary electrophoresis
with laser-induced fluorescent detection (ce-lif) will be able to
measure dopamine changes, as well as extend these findings to determine
the relationship between the different neurotransmitter systems. |
| Title
of Research: |
“Neurochemical
Changes Associated with Increased Motivation for Ethanol Self-Administration.”
|
| Degrees
Received: |
A.A., Pharmacy, University
of Florida, May 2006 |
| Honors
Received: |
2005, President’s
List, National Society of Collegiate Scholars, Alpha Lambda Delta
Honor Society; 2004, Highlands Regional Medical Center Health Scholarship |
| AFPE
Award: |
Wyeth
Pharmaceuticals - AFPE Gateway To Research Scholarship |
|
STEPHANIE
D. ZAUGG
Ohio Northern University College of Pharmacy
|
| Faculty
Sponsor: |
David H. Kinder, Ph.D. |
| Faculty
Sponsor Title: |
Professor, Medicinal Chemistry |
| Major: |
Pharm.D., B.S., Biology,
B.A., Spanish |
| GPA: |
3.84/4.00 |
| Expected
Graduation: |
May 2008 |
| Focus
of Research: |
To use a novel
3D cell culture method to investigate the effect of hormones, in particular
androgens and estrogens, on cancer cell growth in the presence of
the COX-2 inhibitor celecoxib (Celebrex). |
| Title
of Research: |
“Effect
of Celecoxib on the Growth of HT-29 and MDA PCa 2b Prostate Carcinoma
Cell Lines in the Presence of Androgens.” |
| Degrees
Received: |
N/A |
| Honors
Received: |
2006, Rho
Chi National Pharmacy Academic honorary; 2006, Omicron Delta Kappa
National Leadership honorary; 2005 Phi Lambda Sigma National Pharmacy
Leadership honorary; 2005, Beta Beta Beta National Biology honorary;
2005, Mortar Board National Leadership, Scholarship, and service honorary;
2004, Sigma Delta Pi National Spanish Honorary; 2004, Spanish Department
Award; 2004, Resident Assistant of the Year 5 University Parkway/Northern
House; 2003, Alpha Lambda Delta National Scholastic honor Society
for 1st Year College Women |
| AFPE
Award: |
United
States Pharmacopeia (USP) - AFPE Gateway To Research Scholarship |
|
